ecosystem / people / francisco-diaz-mitoma
F

Francisco Diaz-Mitoma

Co-founder, Bowhead Health

Health TechOttawa

Dr. Francisco Diaz-Mitoma is a physician-scientist and vaccine researcher who co-founded Bowhead Health with his son, Francisco Diaz-Mitoma Jr., and is its Chief Medical Officer. A former University of Ottawa professor of medicine and virology, he co-founded VBI Vaccines (originally Variation Biotechnologies) in 2001 and led Sudbury's Advanced Medical Research Institute of Canada until 2015.

Francisco hasn’t spoken on a TechTO, TechVancouver or TechWaterloo stage. This profile is here because Francisco co-founded Bowhead Health, which appears in 1 talk in the archive.

Around the web ×4

Quick answers

What is Francisco Diaz-Mitoma's role at Bowhead Health?

Bowhead Health's team page, checked September 2026, lists Dr. Francisco Diaz-Mitoma, PhD, MD as Co-Founder and Chief Medical Officer. The company's CEO is his son, Francisco Diaz-Mitoma Jr., who is listed separately as Co-Founder and CEO.

How did Bowhead Health start?

DIGITIMES reported on 2024-11-19 that software developer Francisco Diaz-Mitoma Jr. co-founded Bowhead Health together with his father, Dr. Francisco Diaz-Mitoma. The company's own site, checked September 2026, dates Bowhead to 2016 and says it is based in Ottawa.

What did Francisco Diaz-Mitoma do before Bowhead Health?

Sudbury.com reported on 2016-07-26 that he co-founded VBI Vaccines, originally Variation Biotechnologies, in 2001 and was returning to it as chief medical officer after leading Sudbury's Advanced Medical Research Institute of Canada. His Bowhead bio, checked September 2026, says he was Professor of Medicine and Virology at the University of Ottawa.

What vaccines has he worked on?

His Bowhead Health bio, checked September 2026, credits him with contributions to PreHevbrio, a three-antigen hepatitis B vaccine, and to clinical studies of CMV-based immunotherapeutic vaccines for glioblastoma. Sudbury.com reported on 2021-03-11 that a VBI COVID-19 vaccine candidate was heading to clinical trial at The Ottawa Hospital.

Suggest an edit
This is you? Claim this profileAsk to be removed
Know someone who belongs here? Suggest a profile
Maintained by TechTO · facts sourced and dated · last reviewed Sep 18, 2026